Show simple item record

dc.contributor.authorFilocamo, Angela
dc.contributor.authorBisignano, Carlo
dc.contributor.authorFerlazzo, Nadia
dc.contributor.authorCirmi, Santa
dc.contributor.authorMandalari, Giuseppina
dc.contributor.authorNavarra, Michele
dc.date.accessioned2015-09-01T17:53:34Z
dc.date.available2015-09-01T17:53:34Z
dc.date.issued2015-07-30
dc.identifier.citationBMC Complementary and Alternative Medicine. 2015 Jul 30;15(1):256
dc.identifier.urihttp://dx.doi.org/10.1186/s12906-015-0769-2
dc.identifier.urihttp://hdl.handle.net/10724/31902
dc.description.abstractAbstract Background Helicobacter pylori infection has been associated with chronic gastritis, peptic ulcer and gastric carcinoma as over half of the world's population is colonized with this gram-negative bacterium. Due to the increasing antibiotic resistance, its eradication rates fails in a great portion of patients. A number of studies showed that molecules largely distributed in commonly consumed fruits and vegetables may have antimicrobial activity. The aim of the present study was to investigate the effect of bergamot juice (BJ) against Helicobacter pylori in vitro. The potential therapeutic combination between BJ and the antibiotics amoxicillin (AMX), clarithromycin (CLA) and metronidazole (MTZ) has also been evaluated. Methods The minimum inhibitory concentration (MIC) of BJ, AMX, CLA and MTZ against 2 ATCC and 32 clinical isolates of H. pylori was assayed according to CLSI. The checkerboard method was used to determine the efficacy of the association BJ with the three reference antibiotics. Killing curves were performed on the two cagA-positive ATCC strains of H. pylori (ATCC 43504 and ATCC 49503), on the clinical isolate cagA-positive HP6 strain of H. pylori and on the clinical isolate cagA-negative HP61 strain of H. pylori. Results BJ (2.5 %, v/v) inhibited the growth of 50 % of the H. pylori clinical isolates, whereas 5 % (v/v) inhibited 90 %. AMX was the most effective antibiotic against the reference strains and the clinical isolates, followed by CLA and MTZ. In the combination assays, synergism was observed between BJ and AMX and between BJ and MTZ against both the reference strains and the clinical isolates. Indifference was observed between BJ and CLA. Conclusions BJ was effective in vitro against H. pylori and the genotype status of the clinical strains may have an impact on its susceptibility. The synergistic combination of BJ and antibiotics could be used to prevent or treat resistance.
dc.titleIn vitro effect of bergamot (Citrus bergamia) juice against cagA-positive and-negative clinical isolates of Helicobacter pylori
dc.typeJournal Article
dc.date.updated2015-07-29T18:58:14Z
dc.language.rfc3066en
dc.rights.holderFilocamo et al.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record